中文名稱:DDO-5936 | 英文名稱:DDO-5936 |
CAS:2355377-13-6 | 品牌: 一研 |
保存條件: Store at -20°C | 產(chǎn)品類別: 抑制劑 |
Cas : 2355377-13-6 |
產(chǎn)品屬性:
產(chǎn)品名稱 | 規(guī)格 | CAS號 | 型號 |
DDO-5936 | 5 mg 10 mg 25 mg 50 mg | 2355377-13-6 | EY-Y0164665 |
Cas No.2355377-13-6
別名 N/A
化學(xué)名 N/A
分子式 C25H29N5O4S
分子量 495.59
溶解度 N/A
儲存條件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
DDO-5936 is a Hsp90-Cdc37 PPI inhibitor with potency and specificity through binding to a critical site on Hsp90 involving Glu47[1].
DDO-5936 (0~80 mg/kg; p.o.) shows effect at the high dose group[1].DDO-5936 is well tolerated for the absence of serious weight loss. DDO-5936 high dose groups show that tumor cells in the xenografts decreased significantly. DDO-5936 shows limited oral efficiency[1].
[1]. Wang L, et al. Discovery and Optimization of Small Molecules Targeting the Protein-Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer. J Med Chem. 2020;63(3):1281-1297.
.
成立日期 | 2014-06-05 (11年) | 注冊資本 | 100 |
員工人數(shù) | 50-100人 | 年?duì)I業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,抗體,細(xì)胞培養(yǎng),分子生物學(xué),免疫安全 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥130 |
VIP7年
|
東陽市百航化工有限公司
|
2025-01-11 | |
¥3104 |
VIP4年
|
上海博爾森生物科技有限公司
|
2025-01-10 | |
¥2880 |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-01-10 | |
¥298 |
VIP3年
|
TargetMol中國(陶術(shù)生物)
|
2024-12-12 |